Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Psychoneuroendocrinology. 2019 Mar 12;104:219–227. doi: 10.1016/j.psyneuen.2019.03.007

Table 1.

Demographic and clinical characteristics of rMDD and HC participants

Variable rMDD (n = 73)
M (SD)
HC (n = 47)
M (SD)
t or X2 p
Age 22.04 (3.09) 21.61 (2.66) 0.78 .43
Female % (n) 65.7% (48) 65.9% (31) <0.01 .98
Education in years 15.40 (2.47) 16.21 (2.91) 1.63 .11
Verbal IQ Estimate 107.70 (9.72) 107.26 (7.44) 0.26 .79
% UIC (n) 78.1% (57) 76.6% (36) 0.04 .84
Body Mass Indexa 25.13 (4.41) 23.98 (2.88) −1.49 .14
Pre-scan Cortisol (μg/dl) 0.41 (0.46) 0.45 (0.71) −0.88 .379
Post-scan Cortisol (μg/dl)b 0.31 (0.46) 0.39 (0.56) 0.88 .379
HDRS* 4.03 (5.16) 0.38 (.77) 4.81 <.001
Age of MDE Onset 15.53 (2.47) --
Current AD % (n) 17.8% (13) --
Current AD Plusc% (n) 4.1% (3) --
*

Group differences at p <.05

a

Sample n = 107; rMDD n = 64, HC n = 43)

b

Sample n = 102; rMDD n = 65, HC n = 37

c

Refers to currently taking an antidepressant and additional psychiatric medications rMDD = remitted major depressive disorder; HC = Healthy Control; IQ = Intelligence Quotient; UIC = University of Illinois at Chicago; HDRS = Hamilton Depression Rating Scale; MDE = Major Depressive Episode; AD = Antidepressant medication